- Champhekar, Ameya;
- Heymans, Rachel;
- Saco, Justin;
- Turon Font, Guillem;
- Gonzalez, Cynthia;
- Gao, Anne;
- Pham, John;
- Lee, June;
- Maryoung, Ryan;
- Medina, Egmidio;
- Campbell, Katie M;
- Karin, Daniel;
- Austin, David;
- Damioseaux, Robert;
- Ribas, Antoni
Background
Interferon-gamma (IFNγ) exerts potent growth inhibitory effects on a wide range of cancer cells through unknown signaling pathways. We pursued complementary screening approaches to characterize the growth inhibition pathway.Methods
We performed chemical genomics and whole genome targeting CRISPR/Cas9 screens using patient-derived melanoma lines to uncover essential nodes in the IFNγ-mediated growth inhibition pathway. We used transcriptomic profiling to identify cell death pathways activated upon IFNγ exposure. Live imaging experiments coupled with apoptosis assays confirmed the involvement of these pathways in IFNγ-mediated cell death.Results
We show that IFNγ signaling activated ERK. Blocking ERK activation rescued IFNγ-mediated apoptosis in 17 of 23 (~ 74%) cell lines representing BRAF, NRAS, NF1 mutant, and triple wild type subtypes of cutaneous melanoma. ERK signaling induced a stress response, ultimately leading to apoptosis through the activity of DR5 and NOXA proteins.Conclusions
Our results provide a new understanding of the IFNγ growth inhibition pathway, which will be crucial in defining mechanisms of immunotherapy response and resistance.